Deeper than ever bio images thanks to new nanotech
Drug delivery developers could get a boost from a new nanoparticle that can provide deep-tissue imaging.
Drug delivery developers could get a boost from a new nanoparticle that can provide deep-tissue imaging.
Children are not included in enough clinical trials in the US, according to an FDA committee.
Outsourcing-Pharma.com presents its weekly round-up of the latest movers and shakers in the world of pharma, including news from Icon, Althea and PSKW.
Lonza has signed a contract to make preclinical trial supplies of an antibody-drug conjugate (ADC) being developed by Intellect Neurosciences.